Latest Marketing Strategy News

Burgundy Diamond Mines announces a court-approved extension and financing for Arctic Canadian Diamond Company Ltd, alongside appointing Brent Mierau as CFO to steer through ongoing market challenges.

Element 25 has locked in Regroup Australia for long-term mining and ore haulage contracts, streamlining its Butcherbird Expansion Project supply chain and pushing towards a 1.1 Mtpa manganese output.

Locksley Resources’ maiden diamond drilling at the Desert Antimony Mine reveals high-grade antimony mineralisation extending beneath historic underground workings, including a standout 33.51% Sb intercept.

Critical Resources has launched a systematic field exploration program at the Corona Pegmatite Field, aiming to expand its lithium resource pipeline within the Mavis Lake Project in Ontario, Canada.

Pathkey.AI appoints Andrew Farnsworth as CEO, leveraging his defence and AI expertise to drive commercialisation of TrialKey and Chipforge platforms.

Fortuna Metals has appointed mineral sands marketing veteran Ian Hind to lead its marketing strategy as it ramps up drilling at the Mkanda and Kampini rutile projects in Malawi, aiming to advance resource definition and commercial viability in 2026.

Pure Resources has partnered with Oak Ridge National Laboratory to develop a rare earth extraction process from its Garnet Hills garnet, aiming to add critical minerals value alongside its industrial minerals business.

Astron Limited has updated its Donald Rare Earth and Mineral Sands Project with a refreshed Bankable Feasibility Study showing a pre-tax NPV8 of AUD 759 million, strengthened Indigenous agreements, and a targeted Final Investment Decision in Q2 2026.

One Click Group delivered a remarkable 1000% increase in new users and a 64% reduction in acquisition costs in Q1 2026, setting the stage for strong revenue growth ahead of tax season.

Bannerman Energy has locked in a landmark US$321.5 million strategic investment from CNNC Overseas Limited, enabling debt-free construction of its Etango Uranium Project and setting the stage for a Final Investment Decision in H2 2026.

Avecho Biotechnology has exceeded its Phase III CBD insomnia trial recruitment target by 16%, setting the stage for a more robust interim analysis scheduled for June 2026. The company’s commercial partnership with Sandoz AG and strengthened patent portfolio underpin its Australian market strategy.

CONNEQT Health’s Pulse device sales surged to a $7 million annualised run-rate despite a temporary supply hiccup, while the company manages a tight cash runway supported by new R&D loans and related-party funding.